This company listing is no longer active
Learning 2 Sleep L2S Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Learning 2 Sleep L2S's earnings have been declining at an average annual rate of -42.6%, while the Healthcare industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 7.7% per year.
Belangrijke informatie
-42.6%
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 15.7% |
| Inkomstengroei | 7.7% |
| Rendement op eigen vermogen | -129.2% |
| Nettomarge | -292.4% |
| Laatste winstupdate | 30 Jun 2022 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Geen updates
Opbrengsten en kosten
Hoe Learning 2 Sleep L2S geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 22 | 7 | -20 | 0 | 0 |
| 31 Mar 22 | 7 | -18 | 0 | 0 |
| 31 Dec 21 | 7 | -16 | 0 | 0 |
| 31 Dec 20 | 5 | -5 | 0 | 0 |
| 31 Dec 19 | 1 | -5 | 0 | 0 |
| 31 Dec 18 | 0 | -4 | 0 | 0 |
Kwaliteitswinsten: HT60 is currently unprofitable.
Groeiende winstmarge: HT60 is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: HT60 is unprofitable, and losses have increased over the past 5 years at a rate of 42.6% per year.
Versnelling van de groei: Unable to compare HT60's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: HT60 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-23.9%).
Rendement op eigen vermogen
Hoge ROE: HT60 has a negative Return on Equity (-129.21%), as it is currently unprofitable.